Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 679
Selected: 0
NCT IDTitle
NCT05113953A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder
NCT01939353Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder
NCT00763490Trial Of Double Umbilical Cord Blood Transplantation
NCT03238326Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia
NCT03254108Clinical Pharmacology Trial to Investigate the Dose of OPC-61815 Injection Equivalent to Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure
NCT02225067Comparison Study Between C13-CAC Breath Test and 24-hour Gastric pH Monitoring
NCT01739829Open-label Investigation of the Safety and Effectiveness of DIABECELL® in Patients With Type 1 Diabetes Mellitus
NCT01184807Phase 1, Dose-escalation Trial of OPB-51602 in Patients With Advanced Solid Tumors
NCT01649557Multicenter, Open-label, Safety and Tolerability Study
NCT01043250Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients
NCT03376763MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics
NCT00071331EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan
NCT01123707To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
NCT02219009Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
NCT00201955Study of Rebamipide Eye Drops to Treat Dry Eye
NCT00366925CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative Colitis
NCT01214421Tolvaptan Extension Study in Participants With ADPKD
NCT02334787A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects
NCT01057147Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea
NCT01922258Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
NCT05326347A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia
NCT05848700A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia
NCT01925521OPS-2071 Single and Multiple Dose Study to Investigate PK and PD Profile in Healthy Korean Male Subjects.
NCT01013532PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
NCT01854944PET Trial to Assess the Receptor Occupancy of Brexpiprazole in Adult Subjects With Schizophrenia
NCT02722863Samsca Post Marketing Surveillance Study
NCT04115319A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.
NCT02085460A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck Cancer
NCT05248646Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)
NCT00300846A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients
NCT07053891LUPKYNIS Drug-use Results Survey
NCT02969369A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis
NCT01628965A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients
NCT05962216Real-life Assessment of Brexpiprazole (Rexulti) in Schizophrenia and in Depressive Disorders
NCT02442765Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
NCT02293993Phase 1 Study of SGI-110 in Patients With Acute Myeloid Leukemia
NCT00292409A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices
NCT03179787Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism
NCT07322406Kaempferol Absorption and Pharmacokinetics Evaluation
NCT00233363Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome
NCT05926375Effect of HINEX Jelly on Nutritional Status in People With Possible Sarcopenia or Sarcopenia
NCT00002337A Study of Multiple Doses of Vesnarinone in Advanced HIV Disease
NCT02449044International, Multicenter, Study of One-year, Open-label, Titrated Oral Tolvaptan Tablet Administration in Patients With Chronic Hyponatremia
NCT05418101A Study to Evaluate the Safety, PK and PD of VIS171 in Participants (Healthy and With Autoimmune Disease)
NCT01141400The Effect of Patient Cost-Sharing on Antidepressant and Adjunctive Therapy Use
NCT03568500A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
NCT05189977A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline
NCT00201981Study of Rebamipide Eye Drops to Treat Dry Eye
NCT03487770Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder
NCT01562743A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome